#CRAVAT Report
#Created at Monday 12/28/2020 13:02:57
#Report level: variant
#
Variant Annotation																Cancer Genome Interpreter					
UID	Chrom	Position	Ref Base	Alt Base	Note	Coding	Gene	Transcript	Sequence Ontology	cDNA change	Protein Change	All Mappings	Sample Count	Samples	Tags	Association	Biomarker	Drug	Evidence	Source	Tumor Type
1	chr14	104776711	G	T		Yes	AKT1	ENST00000349310.7	missense_variant	c.235C>A	p.Gln79Lys	ENST00000349310.7:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A; ENST00000402615.6:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A; ENST00000407796.6:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A; ENST00000544168.5:AKT1::processed_transcript::; ENST00000554581.5:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A; ENST00000554848.5:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A; ENST00000555380.1:AKT1::processed_transcript::; ENST00000555528.5:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A; ENST00000649815.1:AKT1:P31749:missense_variant:p.Gln79Lys:c.235C>A	0			Resistant	AKT1 (Q79K,E17K)	BRAF inhibitors	Case report	PMID:24265152	Cutaneous melanoma
2	chr9	130873027	T	A		Yes	ABL1	ENST00000318560.6	missense_variant	c.1075T>A	p.Phe359Ile	ENST00000318560.6:ABL1:P00519:missense_variant:p.Phe359Ile:c.1075T>A; ENST00000372348.7:ABL1:P00519:missense_variant:p.Phe378Ile:c.1132T>A	0			Responsive	ABL1 (T315A,F317L,F317V,F317I,F317C,F317I,Y253H,E255K,E255V,F359V,F359C,F359I)	Bosutinib (BCR-ABL inhibitor  3rd gen)	NCCN guidelines	PMID:21562040	Chronic myeloid leukemia
3	chr9	130872201	G	C		Yes	ABL1	ENST00000318560.6	missense_variant	c.895G>C	p.Val299Leu	ENST00000318560.6:ABL1:P00519:missense_variant:p.Val299Leu:c.895G>C; ENST00000372348.7:ABL1:P00519:missense_variant:p.Val318Leu:c.952G>C	0			Responsive	ABL1 (V299L)	Cabozantinib (Pan-kinase inhibitor)	Pre-clinical	PMID:26924578	Any cancer type
4	chr14	104780214	C	T		Yes	AKT1	ENST00000349310.7	missense_variant	c.49G>A	p.Glu17Lys	ENST00000349310.7:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A; ENST00000402615.6:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A; ENST00000407796.6:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A; ENST00000554581.5:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A; ENST00000554848.5:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A; ENST00000555380.1:AKT1::processed_transcript::; ENST00000555528.5:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A; ENST00000649815.1:AKT1:P31749:missense_variant:p.Glu17Lys:c.49G>A	0			Resistant	AKT1 (Q79K,E17K)	BRAF inhibitors	Case report	PMID:24265152	Cutaneous melanoma
#CRAVAT Report
#Created at Monday 12/28/2020 13:02:57
#Report level: gene
#
Variant Annotation					
Gene	Note	Number of Coding Variants	Number of Noncoding Variants	Sequence Ontology	All Sequence Ontologies
AKT1		2	0	missense_variant	missense_variant(0),processed_transcript(0)
ABL1		2	0	missense_variant	missense_variant(0)
#CRAVAT Report
#Created at Monday 12/28/2020 13:02:57
#Report level: sample
#
Variant Annotation	
UID	Sample
1	
2	
3	
4	
#CRAVAT Report
#Created at Monday 12/28/2020 13:02:57
#Report level: mapping
#
Variant Annotation			
Original Line	User Tags	UID	Input File Number
1		1	0
2		2	0
3		3	0
4		4	0
